Antisense therapeutics

[1] SUPPRESSION OF NEOINTIMAL SMOOTH-MUSCLE CELL ACCUMULATION IN-VIVO BY ANTISENSE CDC2 AND CDK2 OLIGONUCLEOTIDES IN RAT CAROTID-ARTERY [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (01) : 16 - 24

[2] IN-VIVO TREATMENT WITH ANTISENSE OLIGODEOXYNUCLEOTIDE TO KAPPA-OPIOID RECEPTORS INHIBITED KAPPA-AGONIST-INDUCED ANALGESIA IN RATS [J]. REGULATORY PEPTIDES, 1994, 54 (01) : 1 - 2

[3] PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7595 - 7599

[4] OLIGODEOXYNUCLEOSIDE PHOSPHORAMIDATES AND PHOSPHOROTHIOATES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) : 7079 - 7083

[5] ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) : 571 - 576

[6] SPECIFIC-INHIBITION OF ENDOGENOUS NEUROPEPTIDE-Y SYNTHESIS IN ARCUATE NUCLEUS BY ANTISENSE OLIGONUCLEOTIDES SUPPRESSES FEEDING-BEHAVIOR AND INSULIN-SECRETION [J]. MOLECULAR BRAIN RESEARCH, 1994, 21 (1-2): : 55 - 61

[7] Akino K, 1996, CANCER RES, V56, P77

[8] AMARATUNGA A, 1993, J BIOL CHEM, V268, P1727

[9] A DECREASE IN ANGIOTENSIN RECEPTOR-BINDING IN RAT-BRAIN NUCLEI BY ANTISENSE OLIGONUCLEOTIDES TO THE ANGIOTENSIN AT(1) RECEPTOR [J]. REGULATORY PEPTIDES, 1995, 59 (02) : 171 - 182

[10] ANTIVIRAL ACTIVITY OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE COMPLEMENTARY TO RNA OF THE HUMAN CYTOMEGALOVIRUS MAJOR IMMEDIATE-EARLY REGION [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) : 1945 - 1954

[1] SUPPRESSION OF NEOINTIMAL SMOOTH-MUSCLE CELL ACCUMULATION IN-VIVO BY ANTISENSE CDC2 AND CDK2 OLIGONUCLEOTIDES IN RAT CAROTID-ARTERY [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (01) : 16 - 24

[2] IN-VIVO TREATMENT WITH ANTISENSE OLIGODEOXYNUCLEOTIDE TO KAPPA-OPIOID RECEPTORS INHIBITED KAPPA-AGONIST-INDUCED ANALGESIA IN RATS [J]. REGULATORY PEPTIDES, 1994, 54 (01) : 1 - 2

[3] PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7595 - 7599

[4] OLIGODEOXYNUCLEOSIDE PHOSPHORAMIDATES AND PHOSPHOROTHIOATES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) : 7079 - 7083

[5] ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) : 571 - 576

[6] SPECIFIC-INHIBITION OF ENDOGENOUS NEUROPEPTIDE-Y SYNTHESIS IN ARCUATE NUCLEUS BY ANTISENSE OLIGONUCLEOTIDES SUPPRESSES FEEDING-BEHAVIOR AND INSULIN-SECRETION [J]. MOLECULAR BRAIN RESEARCH, 1994, 21 (1-2): : 55 - 61

[7] Akino K, 1996, CANCER RES, V56, P77

[8] AMARATUNGA A, 1993, J BIOL CHEM, V268, P1727

[9] A DECREASE IN ANGIOTENSIN RECEPTOR-BINDING IN RAT-BRAIN NUCLEI BY ANTISENSE OLIGONUCLEOTIDES TO THE ANGIOTENSIN AT(1) RECEPTOR [J]. REGULATORY PEPTIDES, 1995, 59 (02) : 171 - 182

[10] ANTIVIRAL ACTIVITY OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE COMPLEMENTARY TO RNA OF THE HUMAN CYTOMEGALOVIRUS MAJOR IMMEDIATE-EARLY REGION [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) : 1945 - 1954